BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 9500554)

  • 1. Epistatic relationship between Waardenburg syndrome genes MITF and PAX3.
    Watanabe A; Takeda K; Ploplis B; Tachibana M
    Nat Genet; 1998 Mar; 18(3):283-6. PubMed ID: 9500554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction among SOX10, PAX3 and MITF, three genes altered in Waardenburg syndrome.
    Bondurand N; Pingault V; Goerich DE; Lemort N; Sock E; Le Caignec C; Wegner M; Goossens M
    Hum Mol Genet; 2000 Aug; 9(13):1907-17. PubMed ID: 10942418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of the microphthalmia-associated transcription factor gene by the Waardenburg syndrome type 4 gene, SOX10.
    Verastegui C; Bille K; Ortonne JP; Ballotti R
    J Biol Chem; 2000 Oct; 275(40):30757-60. PubMed ID: 10938265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The value of MLPA in Waardenburg syndrome.
    Milunsky JM; Maher TA; Ito M; Milunsky A
    Genet Test; 2007; 11(2):179-82. PubMed ID: 17627390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional analysis of Waardenburg syndrome-associated PAX3 and SOX10 mutations: report of a dominant-negative SOX10 mutation in Waardenburg syndrome type II.
    Zhang H; Chen H; Luo H; An J; Sun L; Mei L; He C; Jiang L; Jiang W; Xia K; Li JD; Feng Y
    Hum Genet; 2012 Mar; 131(3):491-503. PubMed ID: 21965087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pax3 target gene recognition occurs through distinct modes that are differentially affected by disease-associated mutations.
    Corry GN; Underhill DA
    Pigment Cell Res; 2005 Dec; 18(6):427-38. PubMed ID: 16280008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The mutational spectrum in Waardenburg syndrome.
    Tassabehji M; Newton VE; Liu XZ; Brady A; Donnai D; Krajewska-Walasek M; Murday V; Norman A; Obersztyn E; Reardon W
    Hum Mol Genet; 1995 Nov; 4(11):2131-7. PubMed ID: 8589691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Double heterozygous mutations of MITF and PAX3 result in Waardenburg syndrome with increased penetrance in pigmentary defects.
    Yang T; Li X; Huang Q; Li L; Chai Y; Sun L; Wang X; Zhu Y; Wang Z; Huang Z; Li Y; Wu H
    Clin Genet; 2013 Jan; 83(1):78-82. PubMed ID: 22320238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcription factor hierarchy in Waardenburg syndrome: regulation of MITF expression by SOX10 and PAX3.
    Potterf SB; Furumura M; Dunn KJ; Arnheiter H; Pavan WJ
    Hum Genet; 2000 Jul; 107(1):1-6. PubMed ID: 10982026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SLUG (SNAI2) deletions in patients with Waardenburg disease.
    Sánchez-Martín M; Rodríguez-García A; Pérez-Losada J; Sagrera A; Read AP; Sánchez-García I
    Hum Mol Genet; 2002 Dec; 11(25):3231-6. PubMed ID: 12444107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mouse models for four types of Waardenburg syndrome.
    Tachibana M; Kobayashi Y; Matsushima Y
    Pigment Cell Res; 2003 Oct; 16(5):448-54. PubMed ID: 12950719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular and clinical characterization of Waardenburg syndrome type I in an Iranian cohort with two novel PAX3 mutations.
    Jalilian N; Tabatabaiefar MA; Farhadi M; Bahrami T; Emamdjomeh H; Noori-Daloii MR
    Gene; 2015 Dec; 574(2):302-7. PubMed ID: 26275939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel PAX3 mutations causing Waardenburg syndrome type 1 in Tunisian patients.
    Trabelsi M; Nouira M; Maazoul F; Kraoua L; Meddeb R; Ouertani I; Chelly I; Benoit V; Besbes G; Mrad R
    Int J Pediatr Otorhinolaryngol; 2017 Dec; 103():14-19. PubMed ID: 29224756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a distal enhancer for the melanocyte-specific promoter of the MITF gene.
    Watanabe K; Takeda K; Yasumoto K; Udono T; Saito H; Ikeda K; Takasaka T; Takahashi K; Kobayashi T; Tachibana M; Shibahara S
    Pigment Cell Res; 2002 Jun; 15(3):201-11. PubMed ID: 12028584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Three cases of Waardenburg syndrome type 2 in a Korean family.
    Choi JH; Moon SK; Lee KH; Lew HM; Chang YH
    Korean J Ophthalmol; 2004 Dec; 18(2):185-9. PubMed ID: 15635834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A splice-site mutation affecting the paired box of PAX3 in a three generation family with Waardenburg syndrome type I (WS1).
    Attaie A; Kim E; Wilcox ER; Lalwani AK
    Mol Cell Probes; 1997 Jun; 11(3):233-6. PubMed ID: 9232624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and functional analysis of a novel mutation in the PAX3 gene associated with Waardenburg syndrome type I.
    Niu Z; Li J; Tang F; Sun J; Wang X; Jiang L; Mei L; Chen H; Liu Y; Cai X; Feng Y; He C
    Gene; 2018 Feb; 642():362-366. PubMed ID: 29158168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel mutations of PAX3, MITF, and SOX10 genes in Chinese patients with type I or type II Waardenburg syndrome.
    Chen H; Jiang L; Xie Z; Mei L; He C; Hu Z; Xia K; Feng Y
    Biochem Biophys Res Commun; 2010 Jun; 397(1):70-4. PubMed ID: 20478267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromosome 13q deletion with Waardenburg syndrome: further evidence for a gene involved in neural crest function on 13q.
    Van Camp G; Van Thienen MN; Handig I; Van Roy B; Rao VS; Milunsky A; Read AP; Baldwin CT; Farrer LA; Bonduelle M
    J Med Genet; 1995 Jul; 32(7):531-6. PubMed ID: 7562965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations in PAX3 that cause Waardenburg syndrome type I: ten new mutations and review of the literature.
    Baldwin CT; Hoth CF; Macina RA; Milunsky A
    Am J Med Genet; 1995 Aug; 58(2):115-22. PubMed ID: 8533800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.